RU2016151761A3 - - Google Patents

Download PDF

Info

Publication number
RU2016151761A3
RU2016151761A3 RU2016151761A RU2016151761A RU2016151761A3 RU 2016151761 A3 RU2016151761 A3 RU 2016151761A3 RU 2016151761 A RU2016151761 A RU 2016151761A RU 2016151761 A RU2016151761 A RU 2016151761A RU 2016151761 A3 RU2016151761 A3 RU 2016151761A3
Authority
RU
Russia
Application number
RU2016151761A
Other languages
Russian (ru)
Other versions
RU2016151761A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54699755&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2016151761(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2016151761A publication Critical patent/RU2016151761A/ru
Publication of RU2016151761A3 publication Critical patent/RU2016151761A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2016151761A 2014-05-28 2015-05-28 Очищенные композиции белков ivig и kh для модулирования лимфоцитов и лечения вируса гепатита b RU2016151761A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462003664P 2014-05-28 2014-05-28
US62/003,664 2014-05-28
PCT/US2015/032807 WO2015184050A1 (en) 2014-05-28 2015-05-28 Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus

Publications (2)

Publication Number Publication Date
RU2016151761A RU2016151761A (ru) 2018-07-03
RU2016151761A3 true RU2016151761A3 (https=) 2018-12-26

Family

ID=54699755

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016151761A RU2016151761A (ru) 2014-05-28 2015-05-28 Очищенные композиции белков ivig и kh для модулирования лимфоцитов и лечения вируса гепатита b

Country Status (10)

Country Link
EP (1) EP3148574B1 (https=)
JP (1) JP2017525752A (https=)
CN (1) CN107106664A (https=)
AU (1) AU2015266997A1 (https=)
BR (1) BR112016027818A2 (https=)
CA (1) CA2949994A1 (https=)
ES (1) ES2878043T3 (https=)
MX (1) MX2016015574A (https=)
RU (1) RU2016151761A (https=)
WO (1) WO2015184050A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015184050A1 (en) 2014-05-28 2015-12-03 Rare Antibody Antigen Supply, Inc. Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus
US20160289300A1 (en) * 2015-04-02 2016-10-06 Kieu Hoang Method of manufacturing intravenous immunoglobulin from fraction iii
CN107921080A (zh) * 2015-04-02 2018-04-17 K·黄 由组分iii制造并纯化出用于静脉注射的凝血酶原复合物浓缩剂的方法以及治疗和预防具有抑制剂的a型血友病或感染了hiv‑1和hiv‑2的b型血友病患者的方法
CN118903378A (zh) * 2024-03-19 2024-11-08 北京达尔文细胞生物科技有限公司 一种蛋白聚合物在治疗渐冻症中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
GB0315248D0 (en) * 2003-06-30 2003-08-06 Hoffmann La Roche HCV regulated protein expression
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
CA2639003A1 (en) 2008-08-20 2010-02-20 Canadian Blood Services Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations
US10233228B2 (en) * 2010-04-09 2019-03-19 Albumedix Ltd Albumin derivatives and variants
WO2011143637A1 (en) * 2010-05-14 2011-11-17 The Regents Of The University Of Colorado, A Body Corporate Improved complement receptor 2 (cr2) targeting groups
WO2015184050A1 (en) 2014-05-28 2015-12-03 Rare Antibody Antigen Supply, Inc. Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus
TW201335181A (zh) 2012-01-31 2013-09-01 Kieu Hoang ５５種新發現的蛋白質之序列及其應用

Also Published As

Publication number Publication date
ES2878043T3 (es) 2021-11-18
EP3148574A4 (en) 2017-04-05
MX2016015574A (es) 2018-05-28
RU2016151761A (ru) 2018-07-03
CN107106664A (zh) 2017-08-29
CA2949994A1 (en) 2015-12-03
WO2015184050A1 (en) 2015-12-03
EP3148574B1 (en) 2021-04-14
JP2017525752A (ja) 2017-09-07
AU2015266997A1 (en) 2016-12-08
BR112016027818A2 (pt) 2017-10-24
EP3148574A1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
BR112016003450A2 (https=)
BR112016017664A2 (https=)
BR112016016432A2 (https=)
BR112016017872A2 (https=)
BR112016016603A2 (https=)
BR112016016682A2 (https=)
BR112016016834A2 (https=)
BR112016018293A2 (https=)
BR112016017913A2 (https=)
BR112016017950A2 (https=)
BR112016017265A2 (https=)
BR112016018369A2 (https=)
BR112016012568A2 (https=)
BR112016016364A2 (https=)
BR112016008129A2 (https=)
BR112016016467A2 (https=)
BR112016016329A2 (https=)
BR112016017526A2 (https=)
BR112016015798A2 (https=)
BR112016017660A2 (https=)
BR112016015779A2 (https=)
BR112016015768A2 (https=)
BR112016017739A2 (https=)
BR112016017221A2 (https=)
BR112016016798A2 (https=)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20200218